2026 – JAZMP

HMA/ema multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations

6. August, 2026 / Artificial intelligence (AI), Medicinal products for human use, Public announcement, Uncategorized

The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) will jointly host the multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations on 12 and 13 November 2026. The event will be held in a hybrid format, with in-person attendance (by invitation only) and online participation available. Coordinated by the Network Data Steering Group (NDSG) in collaboration with the CHMP Methodology Working Party and the ACT EU initiative, the forum offers a valuable opportunity to […]

HMA/ema multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations Read More »

Electronic delivery of documents

7. April, 2026 / Public announcement, Uncategorized

Please be informed that the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) is introducing electronic delivery of issued documents through the new system for

Electronic delivery of documents Read More »

Bridging Innovation and Regulation: Highlights from the IncreaseNET 2026 Innovation Symposium

13. March, 2026 / Dogodek, News about projects, Obvestila za javnost, Projects, Projekti, Public announcement

On 22 January 2026, Zagreb, Croatia, once again became a meeting point for regulatory collaboration as the IncreaseNET 2026 Innovation Symposium: Bridging Innovation and Regulation brought together 134 participants, both

Bridging Innovation and Regulation: Highlights from the IncreaseNET 2026 Innovation Symposium Read More »

What makes an effective External Reference Pricing system today?

6. February, 2026 / Medicine prices, News about projects, Obvestila za javnost, Projects, Projekti, Public announcement

The updated EURIPID Guidance Document on External Reference Pricing (ERP) provides practical, evidence-based insights for policymakers across Europe. A key milestone of the EURIPID ACCESS project has been the update

What makes an effective External Reference Pricing system today? Read More »

JAMS 2.0: Report on joint inspections campaign of medical device manufacturers

30. January, 2026 / News about projects, Obvestila za javnost, Projects, Projekti, Public announcement

JAMS 2.0 project aims to reinforce the market surveillance of medical devices (MD) and in-vitro medical devices (IVD) in EU/EEA Member States to harmonize approaches in this field across the

JAMS 2.0: Report on joint inspections campaign of medical device manufacturers Read More »

Cookie	Duration	Description
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie

HMA/ema multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations

Electronic delivery of documents

Bridging Innovation and Regulation: Highlights from the IncreaseNET 2026 Innovation Symposium

What makes an effective External Reference Pricing system today?

JAMS 2.0: Report on joint inspections campaign of medical device manufacturers

JAZMP

ABOUT AGENCY

QUICK LINKS